Spots Global Cancer Trial Database for Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)

Official Title:

Study ID: NCT05650476

Conditions

Metastatic Castration-Resistant Prostate Cancer

Interventions

Talazoparib

Study Description

Brief Summary: Provide pre-approval single-patient Expanded Access (Compassionate Use) of talazoparib for patients with metastatic castration-resistant prostate cancer.

Detailed Description: In Expanded Access, treating physicians are the Sponsors.. Expanded Access requests from treating physicians may be submitted at www.pfizercares.com; availability will depend on location/country.